ArriVent BioPharma, Inc. engaged PricewaterhouseCoopers LLP as its auditor.
Action
engagement
Auditor
PricewaterhouseCoopers LLP
Exact text from the filing
On March 11, 2025, the Audit Committee appointed PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
ArriVent BioPharma, Inc. dismissed KPMG LLP as its auditor.
Action
dismissal
Auditor
KPMG LLP
Successor
PricewaterhouseCoopers LLP
Exact text from the filing
On March 11, 2025, the Audit Committee (the “Audit Committee”) of the Board of Directors of ArriVent BioPharma, Inc. (the “Company”) approved the dismissal of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.